December 2023 – In Grand Rounds 42, Drs. O'Brien and Fowler engage in a discussion regarding the landscape of Alzheimer's disease (AD) biomarker testing, dive into the potential clinical usefulness of plasma AD biomarkers, and identify the obstacles that hinder the implementation of plasma AD biomarkers.
Speakers
Kyra S. O'Brien, MD
Assistant Professor of Neurology
Penn Memory Center, University of Pennsylvania
Nicole Fowler, PhD, MHSA
Associate Professor of Medicine
Indiana University School of Medicine
Learning Objectives
- Understand the landscape of Alzheimer’s disease (AD) biomarker testing.
- Describe the potential clinical utility of plasma AD biomarkers.
- Identify barriers to plasma AD biomarker implementation in specialist and non-specialist settings.